EDGAR Filing Documents for 0001144204-10-004600

Form 8-K - Current report:

SEC Accession No. 0001144204-10-004600

Filing Date

2010-02-01

Accepted

2010-02-01 06:13:20

Documents

Period of Report

2010-01-25

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	v172794_8k.htm	8-K	29054
2	SUBSCRIPTION AGREEMENT	v172794_ex10-1.htm	EX-10.1	59971
3	COMMON STOCK PURCHASE WARRANT	v172794_ex10-2.htm	EX-10.2	63629
	Complete submission text file	0001144204-10-004600.txt		154436

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019

Business Address 110 EAST 59TH STREET NEW YORK NY 10019 250-519-0553

BRAINSTORM CELL THERAPEUTICS INC (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-61610 | Film No.: 10561671
SIC: 2836 Biological Products, (No Diagnostic Substances)